このアイテムのアクセス数: 747

このアイテムのファイル:
ファイル 記述 サイズフォーマット 
jamanetworkopen.2023.5174.pdf884.58 kBAdobe PDF見る/開く
完全メタデータレコード
DCフィールド言語
dc.contributor.authorInoue, Kosukeen
dc.contributor.authorTsugawa, Yusukeen
dc.contributor.authorMayeda, Elizabeth Roseen
dc.contributor.authorRitz, Beateen
dc.contributor.alternative井上, 浩輔ja
dc.contributor.alternative津川, 友介ja
dc.date.accessioned2023-03-31T06:28:29Z-
dc.date.available2023-03-31T06:28:29Z-
dc.date.issued2023-03-
dc.identifier.urihttp://hdl.handle.net/2433/281527-
dc.description1週間の歩行パターンと死亡リスクの関連を明らかに --週2回しっかり歩くことで健康は維持できるか?--. 京都大学プレスリリース. 2023-03-30.ja
dc.description.abstract[Importance] Previous studies have shown that individuals who regularly walk, particularly 8000 daily steps or more, experience lower mortality. However, little is known about the health benefits of walking intensively only a few days a week. [Objective] To evaluate the dose-response association between the number of days an individual takes 8000 steps or more and mortality among US adults. [Design, Setting, and Participants] This cohort study evaluated a representative sample of participants aged 20 years or older in the National Health and Nutrition Examination Surveys 2005-2006 who wore an accelerometer for 1 week and their mortality data through December 31, 2019. Data were analyzed from April 1, 2022, to January 31, 2023. [Exposures] Participants were grouped by the number of days per week they took 8000 steps or more (0 days, 1-2 days, and 3-7 days). [Main Outcomes and Measures] Multivariable ordinary least squares regression models were used to estimate adjusted risk differences (aRDs) for all-cause and cardiovascular mortality during the 10-year follow-up, adjusting for potential confounders (eg, age, sex, race and ethnicity, insurance status, marital status, smoking, comorbidities, and average daily step counts). [Results] Among 3101 participants (mean [SD] age, 50.5 [18.4] years; 1583 [51.0%] women and 1518 [49.0%] men; 666 [21.5%] Black, 734 [23.7%] Hispanic, 1579 [50.9%] White, and 122 [3.9%] other race and ethnicity), 632 (20.4%) did not take 8000 steps or more any day of the week, 532 (17.2%) took 8000 steps or more 1 to 2 days per week, and 1937 (62.5%) took 8000 steps or more 3 to 7 days per week. Over the 10-year follow-up, all-cause and cardiovascular deaths occurred in 439 (14.2%) and 148 (5.3%) participants, respectively. Compared with participants who walked 8000 steps or more 0 days per week, all-cause mortality risk was lower among those who took 8000 steps or more 1 to 2 days per week (aRD, −14.9%; 95% CI −18.8% to −10.9%) and 3 to 7 days per week (aRD, −16.5%; 95% CI, −20.4% to −12.5%). The dose-response association for both all-cause and cardiovascular mortality risk was curvilinear; the protective association plateaued at 3 days per week. Different thresholds for the number of daily steps between 6000 and 10 000 yielded similar results. [Conclusions and Relevance] In this cohort study of US adults, the number of days per week taking 8000 steps or more was associated with a lower risk of all-cause and cardiovascular mortality in a curvilinear fashion. These findings suggest that individuals may receive substantial health benefits by walking just a couple days a week.en
dc.language.isoeng-
dc.publisherAmerican Medical Association (AMA)en
dc.rights© 2023 Inoue K et al. JAMA Network Open.en
dc.rightsThis is an open access article distributed under the terms of the Creative Commons Attribution 4.0 International (CC BY 4.0) License.en
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/-
dc.titleAssociation of Daily Step Patterns With Mortality in US Adultsen
dc.typejournal article-
dc.type.niitypeJournal Article-
dc.identifier.jtitleJAMA Network Openen
dc.identifier.volume6-
dc.identifier.issue3-
dc.relation.doi10.1001/jamanetworkopen.2023.5174-
dc.textversionpublisher-
dc.identifier.artnume235174-
dc.addressDepartment of Social Epidemiology, Graduate School of Medicine, Kyoto Universityen
dc.addressDivision of General Internal Medicine and Health Services Research, David Geffen School of Medicine at UCLA, Los Angeles; Department of Health Policy and Management, Fielding School of Public Health, University of California, Los Angelesen
dc.addressDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angelesen
dc.addressDepartment of Epidemiology, Fielding School of Public Health, University of California, Los Angeles; Department of Environmental Health Sciences, Fielding School of Public Health, University of California, Los Angeles; Department of Neurology, David Geffen School of Medicine at UCLA, Los Angelesen
dc.identifier.pmid36976556-
dc.relation.urlhttps://www.kyoto-u.ac.jp/ja/research-news/2023-03-30-
dcterms.accessRightsopen access-
datacite.awardNumber21K20900-
datacite.awardNumber22K17392-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-21K20900/-
datacite.awardNumber.urihttps://kaken.nii.ac.jp/grant/KAKENHI-PROJECT-22K17392/-
dc.identifier.eissn2574-3805-
jpcoar.funderName日本学術振興会ja
jpcoar.funderName日本学術振興会ja
jpcoar.awardTitle厳格な降圧管理が心血管予防に効果的である集団の同定と、一般集団への介入効果の検討ja
jpcoar.awardTitle糖尿病を介して心血管疾患を引き起こす社会決定要因の同定と、そのメカニズムの解明ja
出現コレクション:学術雑誌掲載論文等

アイテムの簡略レコードを表示する

Export to RefWorks


出力フォーマット 


このアイテムは次のライセンスが設定されています: クリエイティブ・コモンズ・ライセンス Creative Commons